(Press-News.org) Montréal, April 15, 2013 – A team of researchers at the IRCM, led by Dr. Jean-François Côté, made an important discovery in breast cancer, which will published online this week by the scientific journal Proceedings of the National Academy of Sciences (PNAS). The Montréal scientists identified the DOCK1 protein as a potential target to reduce the progression of metastases in patients suffering from breast cancer, the most common type of cancer in women.
Dr. Côté's laboratory is interested in metastasis, which is the spread of cancer from an organ (or part of an organ) to another. Nearly 90 per cent of cancer patient deaths are attributable to metastasis, thus explaining the importance of understanding the underlying cellular and molecular mechanisms of this harmful process.
"Despite important breakthroughs in breast cancer treatment, few mechanisms are known to explain the spread of metastases," says Dr. Côté, Director of the Cytoskeletal Organization and Cell Migration research unit at the IRCM. "We are looking to identify the proteins that regulate the metastatic process so that new agents can be developed and combined with current treatments."
Two major breast cancer subtypes, HER2+ and Basal, have a tendency to be metastatic and recurrent, and are ultimately associated to a poor survival rate. Research at the IRCM was conducted on the HER2+ type (Human Epidermal growth factor Receptor 2), which represents approximately 25 per cent of breast cancer cases. HER2 positive tumours tend to develop and spread more quickly than other types of tumours.
"By studying a genetic mouse model with HER2+ breast cancer, we identified the protein DOCK1 as an important regulator of metastasis," explains Mélanie Laurin, doctoral student in Dr. Côté's laboratory and first author of the study. "When we eliminated this protein in mice, our results showed a significant decrease in lung metastases. We also discovered that the DOCK1 protein contributes to the growth of tumours."
"To show the correlation between the expression of DOCK1 and breast cancer prognosis, we performed an analysis of several databases of patient genic," adds Dr. Benjamin Haibe-Kains, researcher at the IRCM who collaborated with Dr. Côté's team. "We did indeed discover that high levels of DOCK1 in HER2+ or Basal breast cancer patients are associated with a lower prognosis, or recurrence of the disease."
"Our work defined a new molecule required for the progression of breast cancer to the metastatic stage and allowed us to identify new markers that could become potential targets to stop the progression of metastases," concludes Dr. Côté. "We also showed that a chemical inhibitor of the DOCK1 protein, developed by Dr. Yoshinori Fukui, our collaborator in Japan, can stop the migration of cancerous cells. These results could eventually lead to the development of drugs that would limit the progression of metastatic breast cancer and could thereby improve patient prognosis."
"We are proud to fund this research," comments Melody Enguix, Scientific Communication Advisor at the Canadian Cancer Society. "The findings are another important step toward understanding how we can stop metastases, which are the cause of most breast cancer deaths."
###
About the research project
Several researchers collaborated in this study, including Jean-François Côté, Mélanie Laurin, Benjamin Haibe-Kains (Director of the Bioinformatics and Computational Genomics research unit), Jennifer Huber, Ariane Pelletier and Tarek Houalla from the IRCM; Morag Park and William J. Muller from the Rosalind and Morris Goodman Cancer Research Centre at McGill University; and Yoshinori Fukui from the Medical Institute of Bioregulation at Kyushu University in Japan. Research at the IRCM was funded by the Canadian Cancer Society and the Fonds de recherche du Québec – Santé.
For more information on the published article, entitled Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis, please refer to the PNAS website: http://www.pnas.org/.
Breast cancer statistics
According to the Canadian Cancer Society, breast cancer continues to be the most frequently diagnosed cancer in women, with 22,700 new cases expected in Canada in 2012, which represents approximately one-quarter (26 per cent) of all new cancer cases in women. Breast cancer is the second leading cause of death from cancer in Canadian women. In Quebec, an estimated 5,500 women will be diagnosed with breast cancer and 1,350 will die of breast cancer in 2012.
About Jean-François Côté
Jean-François Côté obtained a PhD in biochemistry from McGill University. He is Associate IRCM Research Professor and Director of the Cytoskeletal Organization and Cell Migration research unit. Dr. Côté is also associate research professor in the Department of Medicine (accreditation in molecular biology) at the Université de Montréal, and adjunct professor in the Department of Medicine (Division of Experimental Medicine) at McGill University. He is a Research Scholar from the Fonds de recherche du Québec – Santé. For more information, visit http://www.ircm.qc.ca/cote.
About the IRCM
Founded in 1967, the Institut de recherches cliniques de Montréal (http://www.ircm.qc.ca) is currently comprised of 35 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, eight core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM Clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University. The IRCM is funded, in part, by the Quebec ministry of Higher Education, Research, Science and Technology.
END
Recently, doctors have begun to categorize breast cancers into four main groups according to the genetic makeup of the cancer cells. Which category a cancer falls into generally determines the best method of treatment.
But cancers in one of the four groups — called "basal-like" or "triple-negative" breast cancer (TNBC) — have been particularly tricky to treat because they usually don't respond to the "receptor-targeted" treatments that are often effective in treating other types of breast cancer. TNBC tends to be more aggressive than the other types and more likely ...
ANN ARBOR—The larger the group, the smaller the chance of forming interracial friendships, a new University of Michigan study shows.
Published in the Proceedings of the National Academy of Sciences, the study examines how the size of a community affects the realization of people's preferences for friends. U-M researchers Siwei Cheng and Yu Xie tested their theoretical model using both simulated and real data on actual friendships among 4,745 U.S. high school students.
"We found that total school size had a major effect on the likelihood that students would form interracial ...
Writers: Emil Venere, (765) 494-4709, venere@purdue.edu
Sources: Ji Soo Yi, 765-496-7213, yij@purdue.edu
Bum chul Kwon, kwonb@purdue.edu
Related Web site:
Ji Soo Yi: http://web.ics.purdue.edu/~yij/
PHOTO CAPTION:
Purdue industrial engineering doctoral candidate Bum chul Kwon demonstrates a new system that allows treadmill users to read while they run. The system, called ReadingMate, adjusts text on a monitor to counteract the bobbing motion of a runner's head so that the text appears still. (Purdue University photo/Mark Simons)
A publication-quality ...
Researchers from Chulalongkorn University, Bangkok and the Natural History Museum, London (Thanit Siriboon, Chirasak Sutcharit, Fred Naggs and Somsak Panha) discovered many new taxa of the brightly coloured carnivorous terrestrial snails family Streptaxidae. Terrestrial snails are primarily herbivores and only a rare few groups like this one are carnivorous. The animals come from several limestone areas across the world, including some threatened by human exploitation, especially by quarrying.
Three new species from the genus Perrottetia were described from north and ...
INDIANAPOLIS and WEST LAFAYETTE, Ind. -- Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.
As health care records move to electronic systems, there is an opportunity to compile information taken from individuals and use it to conduct large studies that advance the entire health care system, said Michael D. Murray, PharmD, MPH, the Regenstrief Institute investigator and Purdue University professor ...
How do nerve cells -- which can each be up to three feet long in humans -- keep from rupturing or falling apart?
Axons, the long, cable-like projections on neurons, are made stronger by a unique modification of the common molecular building block of the cell skeleton. The finding, which may help guide the search for treatments for neurodegenerative diseases, was reported in the April 10 issue of Neuron by researchers at the University of Illinois at Chicago College of Medicine.
Microtubules are long, hollow cylinders that are a component of the cytoskeleton in all cells ...
COLUMBIA, Mo. – People with an Autism Spectrum Disorder (ASD) often have trouble communicating and interacting with others because they process language, facial expressions and social cues differently. Previously, researchers found that propranolol, a drug commonly used to treat high blood pressure, anxiety and panic, could improve the language abilities and social functioning of people with an ASD. Now, University of Missouri investigators say the prescription drug also could help improve the working memory abilities of individuals with autism.
Working memory represents ...
April 15, 2013 – San Francisco - A brain-training task that increases the number of items an individual can remember over a short period of time may boost performance in other problem-solving tasks by enhancing communication between different brain areas. The new study being presented this week in San Francisco is one of a growing number of experiments on how working-memory training can measurably improve a range of skills – from multiplying in your head to reading a complex paragraph.
"Working memory is believed to be a core cognitive function on which many types of ...
AURORA, Colo. (April 15, 2013) – A newly published study of patients with pulmonary fibrosis has discovered multiple genetic variations that should help with future efforts to treat the disease.
Pulmonary fibrosis is a condition where lung tissue becomes thickened, stiff and scarred. Currently in the United States, there are no drugs approved for use in cases of the condition's most common and severe form, which is known as idiopathic pulmonary fibrosis (IPF) because the cause of the disease is not known. In those cases, the median survival time after diagnosis is two ...
As small and active flying mammals, bats have very high mass-specific energy requirements and as such continually adjust their rates of activity and metabolism in response to ambient temperature and other seasonal variation. In particular, during the autumn mating season, male bats must carefully balance time spent foraging (to gain enough fat to last the winter hibernation) with time spent finding a mate. Because both activities require significant effort, how do male bats do it? In an upcoming issue of Physiological and Biochemical Zoology, Nina Becker and colleagues ...
